التفاصيل البيبلوغرافية
| العنوان: |
Implications for Public Health Regulation if Chevron Deference Is Overturned. |
| المؤلفون: |
Agrawal S; Yale Law School, New Haven, Connecticut., Ross JS; Section of General Internal Medicine, Department of Internal Medicine, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, Connecticut.; Deputy Editor, JAMA., Ramachandran R; Section of General Internal Medicine, Department of Internal Medicine, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, Connecticut. |
| المصدر: |
JAMA [JAMA] 2024 May 07; Vol. 331 (17), pp. 1443-1444. |
| نوع المنشور: |
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: Chicago : American Medical Association, 1960- |
| مواضيع طبية MeSH: |
Government Regulation* , Public Health*/legislation & jurisprudence , Supreme Court Decisions* , United States Government Agencies*/legislation & jurisprudence, Humans ; COVID-19/prevention & control ; United States ; COVID-19 Vaccines/therapeutic use |
| فهرسة مساهمة: |
Local Abstract: [plain-language-summary] This Viewpoint describes implications for medicine and public health if the US Supreme Court decides to overturn or narrow Chevron deference. |
| تواريخ الأحداث: |
Date Created: 20240320 Date Completed: 20240507 Latest Revision: 20240515 |
| رمز التحديث: |
20240516 |
| DOI: |
10.1001/jama.2024.3654 |
| PMID: |
38506706 |
| قاعدة البيانات: |
MEDLINE |
